You just read:

Argos Therapeutics' Arcelis™ Immunotherapy for Renal Cell Carcinoma Demonstrates Encouraging Results in Phase 2 Combination Study With Sunitinib

News provided by

Argos Therapeutics

Oct 01, 2010, 08:00 ET